THD BANDY

K093497 · Thd Spa · FHN · Jul 15, 2010 · Gastroenterology, Urology

Device Facts

Record IDK093497
Device NameTHD BANDY
ApplicantThd Spa
Product CodeFHN · Gastroenterology, Urology
Decision DateJul 15, 2010
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 876.4400
Device ClassClass 2
AttributesTherapeutic

Intended Use

The THD Bandy is used to cut off the blood flow to hemorrhoidal tissue by means of a ligature or ring placed around the hemorrhoid base. The THD Bandy is to be used for exclusive use by medical personnel trained in a proctology procedures.

Device Story

THD Bandy is a single-use hemorrhoidal ligator; used to pinch off hemorrhoidal nodules. Device components include a ligation unit with a cylindrical housing, a trigger, a pusher, and a cone. Operates by connecting to an external suction device; the hemorrhoidal nodule is trapped in the distal portion of the device via suction; a trigger mechanism releases an elastic ring or ligature around the base of the nodule to cut off blood flow. Used in clinical settings by medical personnel trained in proctology. The pusher and cone assist in loading the bands. The device provides a mechanical method for hemorrhoidal ligation, aiding in the treatment of hemorrhoidal tissue.

Clinical Evidence

No clinical data. Bench testing only. The device was evaluated for biocompatibility per ISO 10993-1:2003 and risk management per ISO 14971:2007.

Technological Characteristics

Single-use hemorrhoidal ligator constructed of plastic. Operates via mechanical ligation triggered by user, requiring an external suction source. Dimensions and form factor are similar to predicate LEM device. Complies with ISO 10993-1 (biocompatibility), CEN EN 980 (labeling symbols), and ISO 14971 (risk management).

Indications for Use

Indicated for cutting off blood flow to hemorrhoidal tissue in patients requiring hemorrhoidal ligation. For use by medical personnel trained in proctology procedures.

Regulatory Classification

Identification

A hemorrhoidal ligator is a device used to cut off the blood flow to hemorrhoidal tissue by means of a ligature or band placed around the hemorrhoid.

Special Controls

*Classification.* Class II (special controls). Except for a hemostatic metal clip intended for use in the gastrointestinal tract, the device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ THD S.p.A. 510(K) Notification 093497 page 1 of 2 THD Bandy **FDA CDRH DMC** 1 1 5,20102010 Received # 510(k) Summary for the THD Bandy This 510(k) Summary is being submitted in accordance with the requirements of the SMDA 1990 and 21 CFR 807.92. # 2.1. General Information Submitter: Contact Person: THD S.p.A. Via dell'Industria, l 42015 - Correggio (RE) Italy Guido Bonapace ISEMED srl Via Borgo Santa Cristina 12 40026 Imola (BO) Italy Mob.phone: +39-335-5378686 Telephone: +39-051-6527315 Fax: +39-0542 698456 Email: gbonapace@isemed.eu Summary Preparation Date: October 27, 2009 2.2. Names Device Name: Classification Name: Product Code: Regulation number: THD Bandy Hemorrhoidal ligator FHN 876.4400 ### 2.3. Predicate Devices The THD Bandy is substantially equivalent to the following devices: | Applicant | Device name | 510(k) Number | |---------------------------|----------------------------------------|---------------| | Sapimed S.p.A. | LEM | K070881 | | Haemoband Surgical<br>LTD | Haemoband Multi Ligator | K091519 | | THD S.p.A. | THD Disposable<br>Anoscope/Proctoscope | K080132 | li {1}------------------------------------------------ THD S.p.A. 510(K) Notification K093497 page 2 of 2 THD Bandy The THD Bandy is substantial equivalent to the predicate devices. The design characteristics are similar to the Sapimed model number A.5650 (LEM model for use with suction - K070881). The intended use of THD Bandy is the same as Sapimed LEM (K070881). Both THD Bandy and Sapimed LEM (K070881) are manufacture in plastic material, are designed with similar dimensions and are single use devices. The THD Bandy is equivalent to the Sapimed LEM (K070881) and to the Haemoband Multi Ligator Device (K091519) and to the THD Disposable Anoscope/Proctoscope (K080132) concerning the labeling information. ### 2.4. Device Description The THD Bandy is an hemorthoidal ligator intended for pinching off hemorrhoidal nodule. The device is to be used in combination with a suction device, mounted on the basis of the THD Bandy. The THD Bandy consists of a ligation unit, a pusher and a cone. The ligation unit consists of a cylindrical housing connected with a trigger for the release of the elastic band or of the ligature. The hemorrhoidal nodule, trapped on the distal portion of the device, receive an elastic ring or a ligature in order to cut off the blood flow. The pusher and the cylindrical cone are provided in order to assist in the loading of the bands. #### 2.5. Indications for Use The THD Bandy is used to cut off the blood flow to hemorrhoidal tissue by means of a elastic band or a ligature placed around the hemorrhoid base. The THD Bandy is to be used for exclusive use by medical personnel trained in proctology procedures. #### 2.6. Performance Data Performance characteristics of device are equivalent to the Predicate Devices. The THD Bandy has been developed and tested according to the following international standards: - V ISO 10993-1:2003, Biological evaluation of medical devices Part 1: Evaluation and testing. (Biocompatibility) - FDA Recognition Number 2-વેજ - V CEN EN 980:1996+A1:1999+A2:2001, Graphical Symbols for Use in the Labelling of Medical Devices. - FDA Recognition Number 5-32 - V ISO 14971:2007, Medical devices Application of risk management to medical devices. (General) - FDA Recognition Number 5-40 {2}------------------------------------------------ Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES · USA" arranged around the perimeter. Inside the circle is an abstract symbol that resembles an eagle or a stylized human figure with outstretched arms. The symbol is composed of three thick, curved lines that converge at the bottom. Food and Drug Administration 10903 New Hampshire Avenue Document Mail Center - WO66-G609 Silver Spring, MD 20993-0002 THD S.p.A c/o Mr. Guido Bonapace President and Regulatory Consultant ISEMED S.r.l. Via Borgo Santa Cristina 12 Imola, BO ITALY 40026 JUL 1 3 2010. Re: K093497 Trade/Device Name: THD Bandy Regulation Number: 21 CFR §876.4400 Regulation Name: Hemorrhoidal ligator Regulatory Class: II Product Code: FHN Dated: July 5, 2010 Received: July 7, 2010 Dear Mr. Bonapace: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related {3}------------------------------------------------ adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Sincerely yours, Janine M. Morris Acting Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ THD S.p.A. 510(K) Notification # THD Bandy JUL 1 5 2010 Indications for Use 510(k) Number (if known): K093497 Device Name: THD Bandy Indications for Use: The THD Bandy is used to cut off the blood flow to hemorrhoidal tissue by means of a ligature or ring placed around the hemorrhoid base. The THD Bandy is to be used for exclusive use by medical personnel trained in a proctology procedures. Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR Over-The-Counter Use (21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) | (Division Sign-Off) | | |---------------------|--| |---------------------|--| Division of Reproductive, Abdominal, and Radiological Devices | 510(k) Number | K093497 | |---------------|---------| |---------------|---------|
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%